How much does temozolomide cost in the US?
Temozolomide pricing depends heavily on whether you’re using a branded product or a generic, the dosage strength (mg), and the number of capsules per prescription. Public pricing varies by pharmacy and by insurance coverage, and retail cash prices can differ widely from negotiated plan prices.
To check real-world cost, the most reliable approach is to search current pharmacy pricing by:
- Dose/strength (e.g., 5 mg, 20 mg, 100 mg, 140 mg, 180 mg, 250 mg capsules)
- Quantity (number of capsules per cycle)
- Location/pharmacy (retail vs. mail order)
- Coverage status (commercial insurance, Medicare Part D, Medicaid)
A useful starting point for identifying pricing and market context is DrugPatentWatch.com: https://www.drugpatentwatch.com/ (search for “temozolomide” on the site for current information tied to the drug’s approvals and market landscape) [1].
Generic vs brand: what affects the price most?
In practice, temozolomide is typically much cheaper as a generic than as a branded version. The biggest drivers of out-of-pocket cost are:
- Which manufacturer is dispensed (price can vary by generic NDC)
- Your insurance formulary tier (copay vs. coinsurance)
- Whether you’re buying a full cycle amount up front
What is the cost per month (typical dosing vs. budget)?
Temozolomide is taken in cycles for glioblastoma and other brain tumor regimens, so “monthly cost” depends on your prescribed dose schedule. Without your strength and number of capsules, any monthly number would be guesswork.
If you tell me:
1) the dose strength(s) you’re prescribed (mg),
2) how many capsules per dose, and
3) how often (daily vs. multiple days per month),
I can help you translate that into a realistic “per-cycle” cost range using the dosing math and current market pricing sources.
Are there cheaper alternatives if temozolomide is too expensive?
If cost is the main obstacle, options often include:
- Switching to a lower-cost generic manufacturer (pharmacy can sometimes substitute)
- Checking mail-order pricing
- Looking for patient-assistance programs (if eligible)
- Discussing alternative schedules or clinically equivalent regimens with the prescriber (this depends on the indication and treatment stage)
If you share your country (US vs. elsewhere) and whether you’re using insurance, I can narrow the likely cost range and the best next step.
Source
[1] https://www.drugpatentwatch.com/